Belgium· BE-AMP-SAM270767-00
SMOFlipid 200 mg/ml
A fettemulsionen product containing soya oil, registered in Belgium by Fresenius Kabi. The same ATC class is registered in 11 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Fettemulsionen is registered in 11 of 19 countries.
Countries holding a registration under ATC B05BA02 (fettemulsionen), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Fettemulsionen · ATC B05BA02
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Soya Oil
- Manufacturer
- Fresenius Kabi
- Country
- Belgium (BE)
- ATC code
- B05BA02
- ATC class
- Fettemulsionen
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 8
4 priced- be_apb0786574
- be_apb2437093EUR 21.17
- be_apb2437101EUR 31.77
- be_apb2437127EUR 21.17
- be_apb2437135EUR 31.77
- be_apb0786582
- be_apb0786608
- be_apb0786616
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fettemulsionen in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainINTRALIPID 200 mg/ml EMULSION PARA PERFUSIONFresenius Kabi España, S.A.U.
- IcelandIntralipidFresenius Kabi AB
- PolandIntralipid 20%Fresenius Kabi AB
- United KingdomBalneum 84.75% bath oilMawdsley-Brooks & Company Ltd
- United StatesIntralipidBaxter Healthcare Corporation
- Japanダイズ油大塚製薬工場
- FranceINTRALIPIDE 20 %, émulsion pour perfusionFRESENIUS KABI FRANCE
- SwitzerlandBalmed Hermal, Medizinisches OelbadAlmirall AG
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Austria · Balneum
- Czechia · Balneum, Intralipid
- Germany · Balneum Hermal
- United Kingdom (Northern Ireland) · Balneum
- Iceland · Intralipid
- Luxembourg · Balneum Hermal
- Portugal · Banhóleum
- Slovakia · Balneum
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eab180ff-c4e0-48a0-9f00-b18d07881649 GET /v1/drugs/eab180ff-c4e0-48a0-9f00-b18d07881649?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Emulsion for infusion",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "SMOFlipid 200 mg/ml",
"name_fr": "SMOFlipid 200 mg/ml",
"name_nl": "SMOFlipid 200 mg/ml",
"amp_code": "SAM270767-00",
"strengths": [
"60.0000",
"60.0000",
"60.0000",
"60.0000",
"50.0000",
"30.0000",
"30.0000",
"50.0000",
"25.0000",
"25.0000",
"0.3000"
],
"pack_count": 14,
"substances": [
"Soya Oil",
"Triglycerides Medium Chain",
"Glycine max - Glycine soja (Ph.Eur. mixture), Bean, Oil",
"Olive Oil",
"Fish Oil Rich in Omega-3-Acids",
"Olea europaea L., Fruit, Oil - Purified",
"Glycerol",
"Sodium Hydroxide",
"Sodium Oleate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Fat Emulsions",
"authorisation_numbers": [
"BE270767",
"BE270776",
"BE484951",
"BE484942",
"BE539386"
]
}See everything about fettemulsionen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.